EP3518932
TREATMENT OF PROSTATE CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.9.2017EP published:
13.11.2024EP application number:
17823017.3
EPO information:
European Patent Register
Max expiry date:
28.9.2037
Title in English:
TREATMENT OF PROSTATE CANCERLanguage of the patent:
English
Timeline
Today
29.9.2017EP application
13.11.2024EP Publication
Owner
Name:
Sumitomo Pharma Switzerland GmbHAddress:
Aeschengraben 27 Floor 22, 4051 Basel, CH
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
Inventor
Name:
RAJASEKHAR, Vijaykumar ReddyAddress:
Apple Valley California, 92308, US
Name:
JOHNSON, Brendan MarkAddress:
Chapel Hill North Carolina 27514, US
Name:
MACLEAN, David B.Address:
Middletown Rhode Island 02842, US
Name:
SEELY, LynnAddress:
San Mateo California 94402, US
Name:
MUDD, Paul, N.Address:
Cary North Carolina 27519, US
Name:
FAESSEL, Hélène M.Address:
Cambridge, MA 02142, US
Priority
Number:
201662402150 PDate:
30.9.2016Country:
US
Number:
201662402004 PDate:
30.9.2016Country:
US
Classification
Categories:
A61K 31/513, A61P 35/00